Recent Updates
Recently added Catalysts
MRM

Note] This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The

Key Takeaway: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for di

Full Press Release Details

This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this
translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation
or for direct, indirect or any other forms of damages arising from the translation.
Kouji Eguchi
CEO and Representative Director
MEDIROM Healthcare Technologies Inc.
2-3-1 Daiba, Minato-ku,
Tokyo, Japan, 135-0091
Notice of Resolution of the Extraordinary General
Meeting of Shareholders
held on June 8, 2021
MEDIROM Healthcare Technologies Inc. hereby notifies you that the following
resolutions were made at the Extraordinary General Meeting of Shareholders held today.
Details of the Report and Resolutions
1. Matters to be resolved:
Proposal 1: To Approve the Absorption-type Company Split Agreement
This item was approved and passed as proposed.
The outline of the agenda is as described in the "Reference Documents
for Solicitation of Proxy Voting Rights" dated May 24, 2021.
For further information, please contact our Investor Relations.
Investor Relations Team: ir@medirom.co.jp
Last updated: Jun 8, 2021